• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Health journalists from Africa receive grants to report on COVID-19

Home > News

Health journalists from Africa receive grants to report on COVID-19

Researcher working in a laboratory setting
18 May 2022

During a pandemic, media plays a crucial role in communicating public health and policy information. When COVID-19 spread like wildfire in 2020, the role of media as the primary source of public information became more evident. However, as COVID-19 cases continued to scourge, journalists were faced with new challenges in their work.

Understanding how medical science works, knowing how to interpret scientific communications, and factchecking information in the middle of lockdowns became more important than ever. That is why DNDi Africa Regional office organized a journalist workshop in 2020 for 22 health reporters from 12 African countries. Participants were invited from Burkina Faso, Côte d’ Ivoire, Cameroon, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Mali, Somalia, Sudan, Togo, and Uganda.  

The workshop was a hands-on opportunity to foster open discussions with a group of journalists who were already reporting on COVID-19. The objective of the sessions was to give health reporters some key information to better understand how medical research is conducted – especially COVID-19 research in Africa – and better inform their audience about these central issues.

Financed by the French embassy in Nairobi, the workshop was organized around the launch of the ANTICOV clinical trial, a large COVID-19 study organized in in 13 African countries and coordinated by 26 leading African and international R&D institutions. This trial served as an opportunity for reporters to engage with scientists involved in it and report on COVID-19 research activities.

After the workshop, the journalists applied for financial grants to cover health-related stories in their respective countries.

10 reporters were eventually awarded a travel grant to document stories around the clinical trials and COVID-19 research. The stories focused on the impact of the disease, demystifying diagnosis and treatment, and the role of African scientists in COVID-19 research.

Below are some of the stories that were published by the journalists:

  1. Ethiopian press – ‘COVID-19 as a big lesson to reform Africa’s health sector’
  2. Actualité CD (DRC) – RDC : l’impact de la Covid-19 sur la lutte contre la maladie du sommeil (avis des spécialistes)
  3. Univers Sciences (Guinea) – Guinée : les laboratoires de diagnostic équipés pour faire face aux épidémies dont le Coronavirus
  4. KTN News (Kenya) – Kenya’s journey towards human vaccine manufacturing | Health Watch
  5. Africa Blogging (Côte D’Ivoire) – Covid-19 : L’Afrique va-t-elle dompter la pandémie
  6. L’Essor (Mali) – Recherche: Le contrecoup de la COVID-19
  7. The Ethiopian Herald (Ethiopia) – Investing in own clinical trials, narrowing down vaccine inequalities
  8. Africa Blogging (Côte D’Ivoire) – Covid-19 : La Côte d’Ivoire est-elle guérie ?
  9. Science Watch Infos – Les maladies tropicales négligées :: Au top de leur délaissement au Cameroun
  10. Ghana News Agency – COVID-19 sparking Africa’s search for ‘homemade’ cure for other diseases

Photo credit: Lameck Ododo-DNDi

Read, watch, share

Loading...
News
6 Jun 2025

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

News
5 Jun 2025

Meet the DNDi Eastern Africa 2024-2025 Media Fellows

Press releases
5 Jun 2025

Colombia becomes first country to recommend rapid tests to diagnose Chagas disease

Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Press releases
22 May 2025

Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis

Videos
20 May 2025

The Children of the Sierra

Press releases
13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License